| Lizenz: Creative Commons Namensnennung 3.0 de PDF - Veröffentlichte Version (2MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-287868
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.28786
Zusammenfassung
Background: It is known that the new membrane-bound estrogen receptor GPER-1 acts suppressive in breast cancer cells and its expression decreases during disease progression. This study was conducted to evaluate the GPER-1 expression in ovarian cancer and its correlation with progression. Its function was tested in vitro in ovarian cancer cells. PATIENTS AND METHODS: GPER-1 expression was ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags